Copyright © Inderes 2011 - present. All rights reserved.

ArcticZymes Technologies

Less than 1K followers

AZT

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

ArcticZymes Technologies is active in biotechnology. The company specializes in research and development of drugs for the treatment of autoimmune diseases. The main focus is on the development of glucans, the production of immunostimulants, and the analysis of enzymes. The vision is to test and develop the medicine and then further use it for RNA and DNA processes. The company was previously known as Biotec Pharmacon and is headquartered in Tromsø.

Read more
Market cap
-
Turnover
-
Revenue
104.35M
EBIT %
-1.27 %
P/E
-
Dividend yield-%
-
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.